secwatch.observer — SEC 8-K summary
======================================

Issuer:     Verastem, Inc. (VSTM)
CIK:        0001526119
Form:       8-K
Filed at:   2026-03-04T23:59:59+00:00
Accession:  0001104659-26-023462
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Verastem posts updated corporate presentation; no specific financial or clinical data disclosed in filing
--------------------------------------------------------------------------------

- Corporate presentation dated March 4, 2026, furnished as Exhibit 99.1 to Form 8-K.
- Presentation titled 'Delivering Novel Therapies for RAS/MAPK Pathway-Driven Cancers'.
- No revenue, trial results, or other material metrics provided in the 8-K or the exhibit excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1526119/000110465926023462/0001104659-26-023462-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1526119/000110465926023462/tm267866d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-023462

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer